https://doi.org/10.4081/mem.2004.622
Saviour siblings
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The creation of saviour siblings to provide umbilical cord blood or bone marrow to save a sick sibling is fraught with moral dangers. This paper discusses the physical and psychological risks involved to saviour siblings and argues that each child ought to be welcomed for its own sake, rather than for the sake of being used as a means to save another.
The argument centres around recent case histories in the United Kingdom and the Human Fertilisation and Embryology Authority's (HFEA) decision on July 21st 2004 to allow embryos created by IVF to be tested in order to help families to have a child who can serve as a tissue match for a seriously ill sibling. It is argued that The HFEA has not provided sufficient evidence to show that pre-implantation diagnosis itself is free of risks to the child's longterm health; nor has it substantiated its claim that the creation of saviour siblings may benefit whole families.
The paper also points out that the renowned British fertility expert, Professor Lord Winston, has come out strongly against the creation of saviour siblings. Pointing to an unsavoury scenario, he asked what would happen if the umbilical cord blood of the saviour sibling failed to repair the sick sibling? Would the saviour sibling then have to donate bone marrow? And suggesting and even grimmer situation, he asked what might happen if the kidney of the sick sibling failed? His comments clearly show that a child who is not created for its own sake risks being abused and treated as a supply of spare parts.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.